Log in
FREE 15-Day Trial
Intelligent Investor
Intelligent Investor
  1. Home
  2. Research & Advice
  3. Research Tools
  4. Shares
  5. DNX

DenX Limited (ASX: DNX) - Share Price and Research

DELISTED

Intelligent Investor free trial for buy hold sell stock recommendations

DNX General Information +

ASX Code DNX
Website N/A
Industry/Sector Health Care Equipment
Market Cap ($M) n/a
DNX Share Price N/A
Day High N/A
Day Low N/A
Last Close N/A
DNX Share Price Movement N/A
+Security prices are delayed by at least 20 minutes and are indicative only.
Trial Banner Trial Banner Trial Banner
Upsell Banner

DNX Related Research

DenX Limited (DNX) Upcoming Dividends & Yields

Distribution Type Dividend Franking Ex-dividend date Payment date Current Price+ Price 7D Avg Dividend Yield
Final 3¢ 100% 9 Sep 2002 16 Oct 2002 - - -
Interim 10¢ 100% 21 Mar 2002 15 Apr 2002 - - -

See all dividends from DenX Limited (DNX) or use our Upcoming Dividends tool to search for dividends across all ASX-listed securities.

DenX Limited (DNX) Recent ASX Announcements

Headline Annoucement date/time+ Price at announcement+ Current price+ Price 7D Avg Gain/Loss
Suspension from Official Quotation 3 May 2006 9:23AM n/a n/a - n/a
Trading Halt 1 May 2006 10:05AM n/a n/a - n/a
Commitments Test Entity - Third Quarter Report 28 Apr 2006 5:07PM n/a n/a - n/a
  • + Company announcements and prices are delayed by at least 20 minutes. Prices are indicative only.

See all ASX announcements from DenX Limited (DNX) or use our ASX Announcements tool to search for announcements across all ASX-listed securities.

DNX Directors

Name Position Start Date
Mr Angus Matthew Holt Director, Company Secretary 17 Sep 1997
Mr Graeme Lawrence Holt Executive Chairman 26 Mar 1992
Dr Avi Ludomirsky Non-Executive Director 8 Nov 2002
Mr Dan Gilat Non-Executive Director 24 Oct 2005

DenX Limited (DNX) Changes in Directors' Interest & Trades

There are no directors' trades from DenX Limited (DNX). Please use our Changes in directors' interest tool to search for changes & trades across all ASX-listed securities.

DNX Management

Name Position
Chris Klamet Chief Operating Officer

DNX Substantial Shareholders

Under ASX rules large investors and investment funds must disclose when they own more than a 5% stake in -- (DNX). However, you won't necessarily see their names in the company’s annual report, as many trade under nominee names. These shareholders are obliged to provide ongoing substantial notices relating to any change of 1% or more.

Holding Name
73,415,262 (29.37%) CGS Holdings Pty Ltd
5,948,966 (5.34%) Shannos, Anthony Wilson

FAQs about DenX Limited (DNX)

Relative to the previous close share price of , DenX Limited's (DNX) current share price of constitutes a movement of or . DenX Limited's (DNX) share price movement is when compared to 7 days ago and is n/a below DNX's 52-week high of n/a.

DenX Limited (DNX) has a current dividend yield of n/a this year. Last year's dividend yield was n/a. The dividend yield for DNX is a ratio that tells you the percentage of DenX Limited's (DNX) share price that it pays out in dividends each year.

DenX Limited (DNX) last dividend payment was $0.03 per share and was paid on 16 Oct 2002. This last DNX dividend included 100% franking.

DenX Limited (DNX) will release its next Annual Report on n/a. DenX Limited's (DNX) last annual report was released on n/a.

DenX Limited (DNX) is classified as Health Care. Other companies in this sector include CSL Limited (CSL), ResMed Inc. (RMD), Cochlear Limited (COH), and Fisher & Paykel Healthcare Corporation Limited (FPH).

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© 2017 Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.